research:protocols_in_development
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
| research:protocols_in_development [2017/04/16 08:57] – burculantonija | research:protocols_in_development [2019/10/17 17:05] (current) – mary_regina_boland | ||
|---|---|---|---|
| Line 1: | Line 1: | ||
| ====== Protocols under Development ====== | ====== Protocols under Development ====== | ||
| - | * [[research: | + | We currently in the process |
| - | * [[research: | + | |
| - | * [[research: | + | |
| - | * [[research: | + | |
| - | * [[research:comparison_of_combination_treatment_in_hypertension|Comparison of combination treatment in hypertension]] | + | |
| - | * [[research:comparison_of_combination_treatment_in_hypertension|Large-scale modeling of patients with thyroid conditions]] | + | |
| + | All new studies should be posted is the OHDSI Github Study Protocol Sandbox. Please DO NOT post new study materials on this wiki page. | ||
| + | |||
| + | * [[research: | ||
| + | * [[research: | ||
| + | * [[research: | ||
| + | * [[research: | ||
| + | * [[research: | ||
| + | * [[research: Risk of acute kidney injury between conventional NSAIDs and selective COX-2 inhibitors]] | ||
| + | * [[research: Comparison of pathologic bone fracture risk between between Tenofovir and Entecavir in chronic hepatitis B patients]] | ||
| + | * [[research: | ||
| - | | ||
| - | * [[research: | ||
research/protocols_in_development.1492333068.txt.gz · Last modified: by burculantonija
